Akèy › Metiyè › Molecular and Cellular Biologists › Dallas, TX
Molecular and Cellular Biologists nan Dallas, TX: Salè H-1B
273 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Dallas, TX. Salè baz medyàn ofri $67,000; mwatye mitan $61,000–$75,149.
Demann (LCA)273
Salè medyan ofri$67,000
Mwatye salè yo$61,000–$75,149
10yèm–90yèm pousantaj$55,000–$87,000
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $64,296 |
| Nivo II (kalifye) | $70,000 |
| Nivo III (eksperyans) | $75,000 |
| Nivo IV (plen kompetans) | $136,080 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| UT Southwestern Medical Center | 238 | $66,492 |
| Howard Hughes Medical Institute | 10 | $78,786 |
| Texas A&M AgriLife Research | 3 | $54,000 |
| Colossal Biosciences, Inc. | 3 | $136,080 |
| Baylor Research Institute | 3 | $100,000 |
| UT Southwestern Medical Center, Office of International Affairs | 3 | $68,108 |
| Texas Scottish Rite Hospital for Children | 2 | $51,366 |
| Southern Methodist University | 2 | $59,214 |
| Ten20 Medical, LLC | 1 | $80,000 |
| Texas A&M Health Science Center | 1 | $48,000 |
| Vimerse InfoTech Inc | 1 | $60,000 |
| University of Kentucky | 1 | $80,000 |
| Illumina, Inc. | 1 | $167,200 |
| Texas A&M University | 1 | $61,000 |
| ReCode Therapeutics, Inc. | 1 | $76,000 |
| Food and Drug Administration | 1 | $102,768 |
| Signify Bio, Inc. | 1 | $87,200 |
Tit travay
- Postdoctoral Researcher63
- Research Scientist32
- Research Associate30
- Senior Research Associate23
- Assistant Instructor16
- Instructor16
- Computational Biologist II9
- Sr. Research Associate9
- Senior Research Scientist8
- Assistant Professor6
- Computational Scientist - BioHPC6
- Biostatistical Consultant3
- Computational Biologist3
- Postdoctoral Research Associate3
- Data Scientist I3
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).